Amendment #2 to Project Rider #1 of Collaboration Agreement between Magenta Therapeutics, Inc. and National Marrow Donor Program d/b/a Be The Match Biotherapies

Contract Categories: Business Operations › Collaboration Agreements
Summary

Magenta Therapeutics, Inc. and the National Marrow Donor Program (doing business as Be The Match Biotherapies) have agreed to amend their existing collaboration agreement. This amendment updates the payment schedule for consulting services provided by Be The Match Biotherapies during 2020. Magenta will pay a fixed quarterly fee of $25,000, with invoices issued on specified dates for each quarter. All other terms of the original agreement remain unchanged.

Read More Arrow
EX-10.10.4 2 d76599dex10104.htm EX-10.10.4 EX-10.10.4

Exhibit 10.10.4

AMENDMENT #2

TO

PROJECT RIDER #1

COLLABORATION AGREEMENT

This Amendment #2 to Project Rider #1 (“Amendment #2”) is entered into effective as of the date of the final signature executing this Amendment #2 (“Amendment #2 Effective Date”) by and between Magenta Therapeutics, Inc. (“Magenta”) and National Marrow Donor Program d/b/a Be The Match Biotherapies (“BTMB”) (each a “Party” and collectively the “Parties”).

WHEREAS, the Parties executed a Collaboration Agreement, effective November 10, 2017 and a Project Rider, effective December 6, 2017 (as amended by that certain Amendment #1, effective December 6, 2018, “Project Rider #1”); and

WHEREAS, the Parties agree to revise the Payment Schedule of the Project Rider #1.

NOW, THEREFORE, for the valuable consideration contained herein, and intending to be legally bound, Magenta and BTMB agree to the following amendment to be effective as of the Amendment #2 Effective Date as follows:

Amendment to Project Rider #1

 

  1.

Delete the Payment Schedule in Section D. Compensation of BTMB of Project Rider #1 in its entirety and replace it with the following to read as follows:

PAYMENT SCHEDULE

 

For Services provided by BTMB during Calendar Year 2020 (January 1, 2020 through December 31, 2020), Magenta will pay BTMB a fixed price quarterly payment of $25,000.   

BTMB will invoice $25,000 every January 15th for consulting services occurring during the period commencing January 1st and ending March 31st.

 

BTMB will invoice $25,000 every April 15th for consulting services commencing April 1st and ending June 30th.

 

BTMB will invoice $25,000 every July 15th for consulting services commencing July 1st and ending September 30th.

 

BTMB will invoice $25,000 every October 15th for consulting services commencing October 1st and ending December 31st.

[Remainder of page intentionally left blank.]

This Amendment #2 is executed by individuals who are duly authorized to legally bind their respective parties as of the Amendment #2 Effective Date:

 

MAGENTA THERAPEUTICS, INC.     NATIONAL MARROW DONOR PROGRAM d/b/a BE THE MATCH BIOTHERAPIES
By:   /s/ Christina Isacson     By:   /s/ Mary Frey
  Authorized signature       Authorized signature
  Christina Isacson       Mary Frey
  (Typed/Printed Name)       (Typed/Printed Name)
Title:   Chief Business Officer     Title:   Contracts & Procurement Department
Date:   November 13, 2019     Date:   11/12/19

 

2